source
- Veradermics reports positive Phase 3 results for oral baldness pillVeradermics said its experimental oral formulation of minoxidil met the primary goal of its Phase 3 trial, showing significantly more new hair growth over six months compared with placebo. The dru…
- Oruka’s experimental psoriasis drug achieves near-complete skin clearance in Phase 2 trialOruka Therapeutics reported that its experimental IL-23 inhibitor ORKA-001 cleared the skin of 40 of 63 patients (about 63%) in a Phase 2 study, achieving a PASI 100 response at 16 weeks. A further…